Thought you might be interested in this information from Abbott
Laboratories- Ross makers of Similac,
"Nutritional Products

Fundamental changes in global markets present Abbott's nutritional business with
opportunities for growth. Abbott plans to pursue these opportunities in
three ways:

     Continued focus on developing new products, improving existing products and
     developing new packaging;
     Continued expansion of its international presence, especially in
emerging markets
     such as China and Southeast Asia;
     Continued emphasis on identifying and developing new market segments for
     medical and pediatric nutritionals, and capitalizing on the strength of
its pediatric
     sales force.

These strategies will help the company grow this business despite changing
demographics and challenging market conditions. In the United States, births
declined
for the sixth year in a row. At the same time, the percentage of children
covered by the
government-sponsored supplemental food program for women, infants and children
(WIC) has increased. At the other end of the demographic spectrum, Abbott's
adult
nutritional business has been positively affected by an increase in the
number of
consumers over the age of 45. These demographic shifts have prompted aggressive
strategies from Abbott and other players as they contend for share in this
important
market segment.

Outside the United States, economic and political changes in a number of
emerging
economies have led to an increase in discretionary income, which allows
consumers to
benefit from Abbott's broad line of adult and pediatric nutritional products.